Dale’s career has focused on accelerating innovation at the intersection of technology and health sciences to optimize health and business outcomes. He is a member of the Health Information Technology Standards Federal Advisory Committee and a member of the FDA’s National Evaluation System for Technology Planning Board. Dale is also CEO of Novasano Health and Science, a company focused on optimizing medical device outcomes for patients, populations, and business. He led the Novasano team that built the technology platforms for multiple healthcare technology startup ventures. Previously, he was a managing director in the health care practice of PricewaterhouseCoopers, served as the CIO and Associate Director for the National Center for Infectious Diseases and as an advisor in the Office of the National Coordinator for Health Information Technology at HHS, and was a member of the Science and Technology Review Subcommittee of the Science Advisory Board of the FDA.